G. Rezza, “Nirsevimab: a change of paradigm in the prophylaxis of Respiratory Syncytial Virus disease among infants”, Ann Ig, vol. 37, no. 5, pp. 684–688, Jun. 2025, doi: 10.7416/ai.2025.2712.